Lion Street Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Sell |
592
-2
| -0.3% | -$890 | 0.08% | 231 |
|
|
2025
Q1 | $288K | Buy |
+594
| New | +$288K | 0.09% | 209 |
|
|
2024
Q4 | – | Sell |
-570
| Closed | -$265K | – | 278 |
|
|
2024
Q3 | $265K | Buy |
570
+69
| +14% | +$32.1K | 0.09% | 215 |
|
|
2024
Q2 | $235K | Sell |
501
-127
| -20% | -$59.5K | 0.09% | 236 |
|
|
2024
Q1 | $256K | Hold |
628
| – | – | 0.1% | 207 |
|
|
2023
Q4 | $256K | Sell |
628
-4
| -0.6% | -$1.63K | 0.1% | 207 |
|
|
2023
Q3 | $220K | Sell |
632
-865
| -58% | -$301K | 0.07% | 229 |
|
|
2023
Q2 | $277K | Buy |
1,497
+829
| +124% | +$153K | 0.09% | 178 |
|
|
2023
Q1 | $210K | Sell |
668
-764
| -53% | -$241K | 0.07% | 225 |
|
|
2022
Q4 | $265K | Buy |
+1,432
| New | +$265K | 0.14% | 119 |
|
|
2022
Q3 | – | Sell |
-1,432
| Closed | -$263K | – | 170 |
|
|
2022
Q2 | $263K | Buy |
1,432
+157
| +12% | +$28.8K | 0.14% | 120 |
|
|
2022
Q1 | $332K | Sell |
1,275
-189
| -13% | -$49.2K | 0.17% | 96 |
|
|
2021
Q4 | $322K | Buy |
1,464
+32
| +2% | +$7.04K | 0.16% | 101 |
|
|
2021
Q3 | $261K | Buy |
+1,432
| New | +$261K | 0.14% | 117 |
|
|
2020
Q2 | – | Sell |
-15
| Closed | -$4K | – | 401 |
|
|
2020
Q1 | $4K | Buy |
+15
| New | +$4K | 0.02% | 298 |
|